News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Joint Venture Between CHA Biotech and Advanced Cell Technology to be called “Stem Cell & Regenerative Medicine International


12/30/2008 11:43:06 AM

WORCESTER, Mass.--(BUSINESS WIRE)--The joint venture between Advanced Cell Technology, Inc. (OTC:ACTC) and leading Korean-based biotechnology company CHA Biotech Co, Ltd. (CHA), announced today that the company would be named “Stem Cell & Regenerative Medicine International.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES